Read More Pharma Industry News How a proenzyme-based approach from Propanc Biopharma tests the limits of current solid tumor paradigms Can a proenzyme therapy reshape solid tumor treatment models? Explore what Propanc Biopharma’s PRP strategy signals for oncology markets. bySoujanya RaviFebruary 7, 2026